Skip to main content

Table 1 Hepatic grade 3/4 laboratory abnormalities in ART naïve patients on Raltegravir or Efavirenz, both in combination with TDF/FTC.

From: HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?

Adverse Event

Toxicity Criteria Grade 3 or 4

Raltegravir n = 281

Efavirenz n = 282

Total bilirubin

> 2.5 × ULN

2 (0.7)

0 (0.0)

Alkaline phosphatase

> 5 × ULN

0 (0.0)

2 (0.8)

AST

> 5 × ULN

6 (2.1)

5 (1.8)

ALT

> 5 × ULN

5 (1.8)

6 (2.1)

  1. AST aspartate amino transferase; AP alkaline phosphatase; ALT alanine aminotransferase; ULN upper limit of normal